Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6901
-0.0408 (-5.58%)
At close: Aug 28, 2026, 4:00 PM EDT
0.7160
+0.0259 (3.75%)
After-hours: Aug 28, 2026, 6:21 PM EDT
Envoy Medical Revenue
Envoy Medical had revenue of $51.00K in the quarter ending June 30, 2026, a decrease of -34.62%. This brings the company's revenue in the last twelve months to $207.00K, down -6.76% year-over-year. In the year 2025, Envoy Medical had annual revenue of $241.00K with 7.11% growth.
Revenue (ttm)
$207.00K
Revenue Growth
-6.76%
P/S Ratio
257.35
Revenue / Employee
$4,404
Employees
47
Market Cap
53.27M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 241.00K | 16.00K | 7.11% |
| Dec 31, 2024 | 225.00K | -91.00K | -28.80% |
| Dec 31, 2023 | 316.00K | 79.00K | 33.33% |
| Dec 31, 2022 | 237.00K | -73.00K | -23.55% |
| Dec 31, 2021 | 310.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| Xtant Medical Holdings | 109.53M |
| SANUWAVE Health | 44.02M |
| Myomo | 43.26M |
| QT Imaging Holdings | 26.43M |
| Baird Medical Investment Holdings | 22.54M |
| Sensus Healthcare | 17.51M |
| Spectral AI | 15.39M |
COCH News
- 7 days ago - Envoy Medical price target lowered to $2 from $2.50 at H.C. Wainwright - TheFly
- 9 days ago - Envoy Medical Proxy statement: Proxy filing - Filings
- 18 days ago - Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones - Newsfile Corp
- 18 days ago - Envoy Medical Quarterly report: Q2 2026 - Filings
- 18 days ago - Envoy Medical Earnings release: Q2 2026 - Filings
- 23 days ago - Envoy Medical Slides: Investor presentation - Filings
- 4 weeks ago - Envoy Medical initiated with a Buy at Lucid Capital - TheFly
- 5 weeks ago - Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial - Newsfile Corp